#ESMO21: slides, webcasts, abstracts, e-posters, videos & news
Sep 21, 2021 · Find the latest research and updates on cancer immunotherapy, biomarkers, neoantigens and more at the ESMO Congress 2021. Access abstracts, e-posters, slides and webcasts of the presentations by oncology experts from around the world.
ESMO
15 hours ago · ESMO is the leading European society for medical oncology, offering a range of activities and resources for professionals and patients. Find out about the upcoming MAP 2024 congress, the latest news on cancer research and treatment, and …
Meeting Resources | OncologyPRO - ESMO
Find presentations, webcasts, abstracts and more from the European Society for Medical Oncology (ESMO) Congress 2019 in Barcelona, Spain. Search by topic, tumour site, session type, date, presenter and format.
ESMO Congress 2024
Sep 17, 2024 · Find out the latest news and updates on cancer research and care from the ESMO Congress 2024 in Barcelona. Access abstracts, ePosters, guidelines, colloquia, satellite symposia, and more resources from the event.
Aug 22, 2023 · e-poster upload (esmo and eons posters) It is mandatory to prepare an e-Poster, which will be available via searchable screens located onsite in Hall 5 . E-Posters can be uploaded in pptx or PDF format (one [1] slide/page) – maximum file size 500 MB .
Posters - ESMO Congress 2024 - CTI Meeting Technology
Liquid biopsy serve as a potential alternative to repeat invasive biopsy for tumor genomic profiling in patients with metastatic cancer. Circulating tumor cells (CTCs), as a component of liquid biopsies, could be a source of cancer–specific DNA.
The deadline to submit your e-Poster to the ESMO Breast Cancer Congress 2022 virtual platform is Friday, 22 April, 21:00 CEST. Further instructions to access the management presentation system in order to upload your e-Poster will be sent to you by our
New treatment paradigms in pancreatic adenocarcinoma - Daily …
Oct 22, 2023 · Four clinical trials presented at the ESMO Congress 2023 (Madrid, 20–24 October) explore different innovative strategies to improve treatment of patients with pancreatic cancer.
AZD9592 is a novel antibody drug conjugate (ADC) that targets EGFR and cMET, two co-expressed receptors in many tumor types. Learn about AstraZeneca's ADC platform, pipeline, and clinical data for AZD9592 in advanced solid tumors.
NSCLC poster presented at ESMO 2024 - cor2ed.com
A group of international multidisciplinary clinical experts and Patient Advocacy Group representatives designed a global survey to assess the awareness and understanding of biomarker testing among patients with non-small cell lung cancer (NSCLC) and their caregivers.